Affiliation:
1. Clinical Director, Physics Clinic for Integrative Medicine , Tokyo , Japan
Abstract
Abstract
Objectives
The support provided by conventional treatments centered on the administration of medication for chronic or other types of depression is limited. Integrative medicine, which is based on both modern Western medicine and a range of complementary and alternative medicine practices, is patient-centered and promotes natural healing in patients to achieve significant cure. This report focuses on the indications of recovery from depression using integrative medicine, especially homeopathy.
Methods
Thirty-one patients (9 males and 22 females) with depression underwent homeopathic treatment using various strategies over 3 months, in addition to antidepressants. All patients were diagnosed with Major Depressive Disorders, except bipolar disorders. Three steps were used to model indications of their recovery from depression: reducing difficulties in everyday life, reducing and stopping antidepressants, and reducing and stopping the homeopathic remedies. Patients were considered to have recovered when antidepressants had been stopped for 6 months or more and 3 or more months had passed since homeopathic medicines were stopped.
Results
Of the 31 patients with depression, 13 recovered within 2 years of starting homeopathic treatment, and 11 completely recovered from chronic depression.
Conclusions
This study suggests that integrative medicine can be a useful strategy for depression, including the use of a three-step strategy for reducing all dependence on clinical treatment. As most patients, especially chronic patients, significantly recovered from depression through homeopathy over 2 years, this model can help understand recovery from depression through integrative medicine.
Subject
Complementary and alternative medicine
Reference32 articles.
1. World Health Organization. “Depression: let’s talk” say WHO, as depression tops list of causes of ill health [Online]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression [Accessed 15 Nov 2020].
2. Ministry of Health, Labour and Welfare. Available from: https://www.mhlw.go.jp/wp/hakusyo/jisatsu/19/dl/1-1.pdf [Accessed 15 Nov 2020].
3. Carvalho, AF, Cavalcante, JL, Castelo, MS, Lima, MC. Augmentation strategies for treatment-resistant depression: a literature review. J Clin Pharm Therapeut 2007;32:415–28. https://doi.org/10.1111/j.1365-2710.2007.00846.x.
4. Thase, ME, Haight, BR, Richard, N, Rockett, CB, Mitton, M, Modell, JG. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatr 2005;66:974–81. https://doi.org/10.4088/jcp.v66n0803.
5. Machado, M, Iskedjian, M, Ruiz, I, Einarson, TR. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials. Curr Med Res Opin 2006;22:1825–37. https://doi.org/10.1185/030079906X132415.